In this educational initiative, expert faculty address barriers to achieving safe and effective moderate to deep neuromuscular blockade and reversal in the perioperative setting. Patient cases are used to provide real world patient management strategies for addressing issues related to neuromuscular blockade and reversal.
In this interprofessional activity, expert faculty will use patient cases to discuss the clinical effects of neuromuscular blocking and reversal agents, including key components of NMB and reversal during the intraoperative phase of care and neuromuscular monitoring. Criteria for use, dosing of specific reversal agents and assessment of risk factors and mitigation of post-operative complications will also be discussed.
This educational activity focuses on clinical challenges and controversies related to neuromuscular blockade reversal. Expert faculty will focus on reversal strategies for neuromuscular blockade in specific high-risk patient populations as well as develop a plan for reversal based on clinical and neuromuscular patient assessments. Team-based collaboration strategies for reversal agent selection and dosing will also be discussed.
Expert faculty discuss current challenges and overcoming barriers to achieve safe and effective moderate to deep neuromuscular blockade and reversal.
Clinical Conversations on Neuromuscular Blockade and Reversal Strategies
Continuing the Dialogue: Clinical Conversations on Neuromuscular Blockade and Reversal Strategies
Expert faculty reflect on overcoming barriers to achieve safe and effective moderate to deep neuromuscular blockade and reversal.
Revising Thoughts on Neuromuscular Blocking Reversal Agents
Residual Neuromuscular Blockade: Not Just Relevant to the Anesthesiologist